ASND · Ascendis Pharma A/S · Documents

$234.33 +4.38 (+1.90%) At close · Oct 20

Market Cap

$15.39B

65.80M

Volume · Oct 20 394.83K Avg daily vol (3M) 686.74K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2025-10-15	—
6-K	—	2025-10-08	—
6-K	—	2025-09-30	—
6-K	—	2025-09-10	—
6-K	—	2025-08-13	—
6-K	—	2025-08-07	2025-06-30
6-K	—	2025-08-07	—
6-K	—	2025-07-28	—
6-K	—	2025-07-09	—
6-K	—	2025-06-27	—
6-K	—	2025-06-11	—
6-K	—	2025-06-09	—
6-K	—	2025-06-09	—
6-K	—	2025-06-02	—
6-K	—	2025-05-28	—
6-K	—	2025-05-14	—
6-K	—	2025-05-01	2025-03-31
6-K	—	2025-05-01	—
6-K	—	2025-04-29	—
6-K	—	2025-04-09	—
6-K	—	2025-03-31	—
6-K	—	2025-03-28	—
6-K	—	2025-03-20	—
6-K	—	2025-03-12	—
20-F	—	2025-02-12	2024-12-31
6-K	—	2025-02-12	—
6-K	—	2025-02-12	—
6-K	—	2025-02-12	—
6-K	—	2025-01-15	—
6-K	—	2025-01-13	—
6-K	—	2025-01-13	—
6-K	—	2024-12-30	—
6-K	—	2024-12-17	—
6-K	—	2024-12-12	—
6-K	—	2024-12-11	—
6-K	—	2024-11-14	—
6-K	—	2024-11-14	2024-09-30
6-K	—	2024-11-13	—
6-K	—	2024-11-04	—
6-K	—	2024-10-09	—
6-K	—	2024-09-30	—
6-K	—	2024-09-27	—
6-K	—	2024-09-23	—
F-3ASR	—	2024-09-18	—
6-K	—	2024-09-16	—
6-K	—	2024-09-16	—
6-K	—	2024-09-12	2024-09-11
6-K	—	2024-09-11	—
6-K	—	2024-09-03	—
6-K	—	2024-09-03	—

Showing 51–100 of 299 filings

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 32 filings 32 filers Visit website Investor relations